Fibrinogen Early In Severe Trauma studY (FEISTY): Study protocol for a randomised controlled trial

Trials

Volumn 18, Issue 1, 2017, Pages

  Winearls, James ^a,b,c   Wullschleger, Martin ^a,c   Wake, Elizabeth ^a   Hurn, Catherine ^b,d   Furyk, Jeremy ^e   Ryan, Glenn ^f   Trout, Melita ^e   Walsham, James ^b,f   Holley, Anthony ^b,d   Cohen, Jeremy ^b,d   Shuttleworth, Megan ^c   Dyer, Wayne ^g   Keijzers, Gerben ^a,c,h   Fraser, John F ^b   Presneill, Jeffrey ⁱ   Campbell, Don ^a  

^a GOLD COAST UNIVERSITY HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e TOWNSVILLE HOSPITAL   (Australia)

^f PRINCESS ALEXANDRA HOSPITAL   (Australia)

^g AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^h BOND UNIVERSITY   (Australia)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cryoprecipitate; Fibrinogen; Fibrinogen concentrate; Haemorrhage; ROTEM ; Trauma

Indexed keywords

BLOOD CLOTTING FACTOR 8 CRYOPRECIPITATE; FIBRINOGEN CONCENTRATE; BLOOD CLOTTING FACTOR 8; CRYOPRECIPITATE COAGULUM; FIBRINOGEN; HEMOSTATIC AGENT;

ADULT; ARTICLE; AUSTRALIA; BLEEDING; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; EARLY INTERVENTION; FEASIBILITY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PILOT STUDY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; THROMBOELASTOGRAPH; THROMBOELASTOGRAPHY; TREATMENT RESPONSE; BLOOD; BLOOD TRANSFUSION; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECTS; HEMOSTASIS; HEMOSTATIC TECHNIQUE; INJURY; METHODOLOGY; MORTALITY; QUEENSLAND; TIME FACTOR; TREATMENT OUTCOME;

BLOOD TRANSFUSION; CLINICAL PROTOCOLS; FACTOR VIII; FEASIBILITY STUDIES; FIBRINOGEN; HEMORRHAGE; HEMOSTASIS; HEMOSTATIC TECHNIQUES; HEMOSTATICS; HUMANS; PILOT PROJECTS; QUEENSLAND; RESEARCH DESIGN; TIME FACTORS; TREATMENT OUTCOME; WOUNDS AND INJURIES;

EID: 85020196876     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-017-1980-x     Document Type: Article

References (72)

1. Cothren CC, Moore EE, Hedegaard HB, Meng K. Epidemiology of urban trauma deaths: a comprehensive reassessment 10 years later. World J Surg. 2007;31(7):1507-11. Epub 2007/05/17.eng.
2. Kauvar DS, Wade CE. The epidemiology and modern management of traumatic hemorrhage: US and international perspectives. Crit Care. 2005;9 Suppl 5:S1-9. PubMed Central PMCID: PMC3226117, Epub 2005/10/14.eng.
3. Brohi K, Cohen MJ, Davenport RA. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care. 2007;13(6):680-5. Epub 2007/11/03.eng.
4. Dobson GP, Letson HL, Sharma R, Sheppard FR, Cap AP. Mechanisms of early trauma-induced coagulopathy: The clot thickens or not? J Trauma Acute Care Surg. 2015;79(2):301-9. Epub 2015/07/29.eng.
5. Hoffman M. Monroe 3rd DM. A cell-based model of hemostasis. Thromb Haemost. 2001;85(6):958-65. Epub 2001/07/04.eng.
6. Levy JH, Welsby I, Goodnough LT. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion. 2014;54(5):1389-405. quiz 8. Epub 2013/10/15.eng.
7. Lang T, Johanning K, Metzler H, Piepenbrock S, Solomon C, Rahe-Meyer N, et al. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg. 2009;108(3):751-8. Epub 2009/02/20.eng.
8. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost. 2005;3(8):1894-904. Epub 2005/08/17.eng.
9. Hagemo JS, Stanworth S, Juffermans NP, Brohi K, Cohen M, Johansson PI, et al. Prevalence, predictors and outcome of hypofibrinogenaemia in trauma: a multicentre observational study. Crit Care. 2014;18(2):R52. PubMed Central PMCID: PMC4056526, Epub 2014/03/29.eng.
10. Floccard B, Rugeri L, Faure A, Saint Denis M, Boyle EM, Peguet O, et al. Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury. 2012;43(1):26-32. Epub 2010/11/30.eng.
11. Schochl H, Cotton B, Inaba K, Nienaber U, Fischer H, Voelckel W, et al. FIBTEM provides early prediction of massive transfusion in trauma. Crit Care. 2011;15(6):R265. PubMed Central PMCID: PMC3388656, Epub 2011/11/15.eng.
12. Inaba K, Karamanos E, Lustenberger T, Schochl H, Shulman I, Nelson J, et al. Impact of fibrinogen levels on outcomes after acute injury in patients requiring a massive transfusion. J Am Coll Surg. 2013;216(2):290-7. Epub 2012/12/06.eng.
13. Rourke C, Curry N, Khan S, Taylor R, Raza I, Davenport R, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost. 2012;10(7):1342-51. Epub 2012/04/24.eng.
14. Innerhofer P, Westermann I, Tauber H, Breitkopf R, Fries D, Kastenberger T, et al. The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury. 2013;44(2):209-16. Epub 2012/09/25.eng.
15. Morrison JJ, Ross JD, Dubose JJ, Jansen JO, Midwinter MJ, Rasmussen TE. Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study. JAMA Surg. 2013;148(3):218-25. Epub 2013/05/15.eng.
16. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016;20(1):100. PubMed Central PMCID: PMC4828865, Epub 2016/04/14.eng.
17. Holcomb JB, Gumbert S. Potential value of protocols in substantially bleeding trauma patients. Curr Opin Anaesthesiol. 2013;26(2):215-20. Epub 2013/02/07.eng.
18. Holcomb JB, Pati S. Optimal trauma resuscitation with plasma as the primary resuscitative fluid: the surgeon's perspective. Hematology Am Soc Hematol Educ Program. 2013;2013:656-9. Epub 2013/12/10.eng.
19. Dutton RP. Management of traumatic haemorrhage-the US perspective. Anaesthesia. 2015;70 Suppl 1:108-e38. Epub 2014/12/03.eng.
20. Schochl H, Voelckel W, Schlimp CJ. Management of traumatic haemorrhage-the European perspective. Anaesthesia. 2015;70 Suppl 1: 102-e37. Epub 2014/12/03.eng.
21. Schochl H, Maegele M, Voelckel W. Fixed ratio versus goal-directed therapy in trauma. Curr Opin Anaesthesiol. 2016;29(2):234-44. Epub 2015/11/26.eng.
22. Johansson PI, Stensballe J, Oliveri R, Wade CE, Ostrowski SR, Holcomb JB. How I treat patients with massive hemorrhage. Blood. 2014;124(20):3052-8. Epub 2014/10/09.eng.
23. Chowdary P, Saayman AG, Paulus U, Findlay GP, Collins PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol. 2004; 125(1):69-73. Epub 2004/03/16.eng.
24. Khan S, Davenport R, Raza I, Glasgow S, De'Ath HD, Johansson PI, et al. Damage control resuscitation using blood component therapy in standard doses has a limited effect on coagulopathy during trauma hemorrhage. Intensive Care Med. 2015;41(2):239-47. Epub 2014/12/03.eng.
25. Kozek-Langenecker S, Sorensen B, Hess JR, Spahn DR. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care. 2011;15(5):R239. PubMed Central PMCID: PMC3334790, Epub 2011/10/18.eng.
26. Ranucci M, Solomon C. Supplementation of fibrinogen in acquired bleeding disorders: experience, evidence, guidelines, and licences. Br J Anaesth. 2012; 109(2):135-7. Epub 2012/07/12.eng.
27. Nascimento B, Goodnough LT, Levy JH. Cryoprecipitate therapy. Br J Anaesth. 2014;113(6):922-34. Epub 2014/06/29. Eng.
28. Curry N, Rourke C, Davenport R, Beer S, Pankhurst L, Deary A, et al. Early cryoprecipitate for major haemorrhage in trauma: a randomised controlled feasibility trial. Br J Anaesth. 2015;115(1):76-83. Epub 2015/05/21.eng.
29. Okerberg CK, Williams LA, 3rd, Kilgore ML, Kim CH, Marques MB, Schwartz J, et al. Cryoprecipitate AHF vs. fibrinogen concentrates for fibrinogen replacement in acquired bleeding patients-an economic evaluation. Vox Sang. 2016 Jun 1. Epub 2016/06/02. Eng.
30. Cotton BA, Dossett LA, Haut ER, Shafi S, Nunez TC, Au BK, et al. Multicenter validation of a simplified score to predict massive transfusion in trauma. J Trauma. 2010;69 Suppl 1:S33-9. Epub 2010/08/05.eng.
31. Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313(5):471-82. Epub 2015/02/04.eng.
32. Nunez TC, Voskresensky IV, Dossett LA, Shinall R, Dutton WD, Cotton BA. Early prediction of massive transfusion in trauma: simple as ABC (assessment of blood consumption)? J Trauma. 2009;66(2):346-52. Epub 2009/02/11.eng.
33. Cotton BA, Reddy N, Hatch QM, LeFebvre E, Wade CE, Kozar RA, et al. Damage control resuscitation is associated with a reduction in resuscitation volumes and improvement in survival in 390 damage control laparotomy patients. Ann Surg. 2011;254(4):598-605. PubMed Central PMCID: PMC3816774, Epub 2011/09/16.eng.
34. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81(3):515-26.
35. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ. 1990;300(6719):230-5. PubMed Central PMCID: PMC1662068, Epub 1990/01/27. Eng.
36. Hanley JA, Negassa A, Edwardes MD, Forrester JE. Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol. 2003;157(4):364-75. Epub 2003/02/13. Eng.
37. Chambers LA, Chow SJ, Shaffer LE. Frequency and characteristics of coagulopathy in trauma patients treated with a low- or high-plasmacontent massive transfusion protocol. Am J Clin Pathol. 2011;136(3):364-70. Epub 2011/08/19.eng.
38. Holcomb JB, Fox EE, Zhang X, White N, Wade CE, Cotton BA, et al. Cryoprecipitate use in the PROMMTT study. J Trauma Acute Care Surg. 2013;75(1 Suppl 1):S31-9. PubMed Central PMCID: PMC3736696, Epub 2013/08/15.eng.
39. Stanworth SJ, Davenport R, Curry N, Seeney F, Eaglestone S, Edwards A, et al. Mortality from trauma haemorrhage and opportunities for improvement in transfusion practice. Br J Surg. 2016;103(4):357-65. Epub 2016/02/05.eng.
40. Nascimento B, Callum J, Tien H, Peng H, Rizoli S, Karanicolas P, et al. Fibrinogen in the initial resuscitation of severe trauma (FiiRST): a randomized feasibility trial. Br J Anaesth. 2016;117(6):775-82. Epub 2016/12/14.eng.
41. Da Luz LT, Nascimento B, Shankarakutty AK, Rizoli S, Adhikari NK. Effect of thromboelastography (TEG(R)) and rotational thromboelastometry (ROTEM(R)) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review. Crit Care. 2014;18(5):518. PubMed Central PMCID: PMC4206701, Epub 2014/09/28.eng.
42. Hunt H, Stanworth S, Curry N, Woolley T, Cooper C, Ukoumunne O, et al. Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma induced coagulopathy in adult trauma patients with bleeding. Cochrane Database Syst Rev. 2015;2:CD010438. Epub 2015/02/17.eng.
43. Gonzalez E, Moore EE, Moore HB, Chapman MP, Chin TL, Ghasabyan A, et al. Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays. Ann Surg. 2015 Dec 28. Epub 2016/01/01. Eng.
44. Holcomb JB, Minei KM, Scerbo ML, Radwan ZA, Wade CE, Kozar RA, et al. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg. 2012;256(3):476-86. Epub 2012/08/08.eng.
45. Hagemo JS, Christiaans SC, Stanworth SJ, Brohi K, Johansson PI, Goslings JC, et al. Detection of acute traumatic coagulopathy and massive transfusion requirements by means of rotational thromboelastometry: an international prospective validation study. Crit Care. 2015;19:97. PubMed Central PMCID: PMC4374411. Epub 2015/04/19.eng.
46. Meyer AS, Meyer MA, Sorensen AM, Rasmussen LS, Hansen MB, Holcomb JB, et al. Thrombelastography and rotational thromboelastometry early amplitudes in 182 trauma patients with clinical suspicion of severe injury. J Trauma Acute Care Surg. 2014;76(3):682-90. Epub 2014/02/21.eng.
47. Meyer MA, Ostrowski SR, Sorensen AM, Meyer AS, Holcomb JB, Wade CE, et al. Fibrinogen in trauma, an evaluation of thrombelastography and rotational thromboelastometry fibrinogen assays. J Surg Res. 2015;194(2):581-90. Epub 2014/12/17.eng.
48. Gorlinger K, Dirkmann D, Solomon C, Hanke AA. Fast interpretation of thromboelastometry in non-cardiac surgery: reliability in patients with hypo-, normo-, and hypercoagulability. Br J Anaesth. 2013;110(2):222-30. Epub 2012/11/01.eng.
49. Winearls J, Mitra B, Reade MC. Haemotherapy algorithm for the management of trauma-induced coagulopathy: an Australian perspective. Curr Opin Anaesthesiol. 2017 Feb 01. Epub 2017/02/06.eng.
50. Gruen RL, Jacobs IG, Reade MC. Trauma and tranexamic acid. Med J Aust. 2013;199(5):310-1. Epub 2013/09/03.eng.
51. Collins PW, Solomon C, Sutor K, Crispin D, Hochleitner G, Rizoli S, et al. Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate. Br J Anaesth. 2014;113(4): 585-95. PubMed Central PMCID: PMC4166889, Epub 2014/07/30.eng.
52. Maegele M, Zinser M, Schlimp C, Schochl H, Fries D. Injectable hemostatic adjuncts in trauma: fibrinogen and the FIinTIC study. J Trauma Acute Care Surg. 2015;78(6 Suppl 1):S76-82. Epub 2015/05/24.eng.
53. Steinmetz J, Sorensen AM, Henriksen HH, Lange T, Larsen CF, Johansson PI, et al. Pilot Randomized trial of Fibrinogen in Trauma Haemorrhage (PRooFiTH): study protocol for a randomized controlled trial. Trials. 2016;17(1):327. PubMed Central PMCID: PMC4949907, Epub 2016/07/20.eng.
54. Nascimento B, Rizoli S, Rubenfeld G, Fukushima R, Ahmed N, Nathens A, et al. Cryoprecipitate transfusion: assessing appropriateness and dosing in trauma. Transfus Med. 2011;21(6):394-401. Epub 2011/08/20.eng.
55. Theodoulou A, Berryman J, Nathwani A, Scully M. Comparison of cryoprecipitate with fibrinogen concentrate for acquired hypofibrinogenaemia. Transfus Apher Sci. 2012;46(2):159-62. Epub 2012/01/10.eng.
56. Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Sorensen B. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth. 2008;101(6):769-73. Epub 2008/09/27.eng.
57. Solomon C, Pichlmaier U, Schoechl H, Hagl C, Raymondos K, Scheinichen D, et al. Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery. Br J Anaesth. 2010;104(5):555-62. PubMed Central PMCID: PMC2855672, Epub 2010/ 03/30.eng.
58. Danes AF, Cuenca LG, Bueno SR, Mendarte Barrenechea L, Ronsano JB. Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding. Vox Sang. 2008;94(3):221-6. Epub 2008/01/09.eng.
59. Beyerle A, Nolte MW, Solomon C, Herzog E, Dickneite G. Analysis of the safety and pharmacodynamics of human fibrinogen concentrate in animals. Toxicol Appl Pharmacol. 2014;280(1):70-7. Epub 2014/08/08.eng.
60. Solomon C, Groner A, Ye J, Pendrak I. Safety of fibrinogen concentrate: analysis of more than 27 years of pharmacovigilance data. Thromb Haemost. 2015;113(4):759-71. Epub 2014/12/17.eng.
61. Schochl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care. 2010;14(2): R55. PubMed Central PMCID: PMC2887173, Epub 2010/04/09.eng.
62. Lin DM, Murphy LS, Tran MH. Use of prothrombin complex concentrates and fibrinogen concentrates in the perioperative setting: a systematic review. Transfus Med Rev. 2013;27(2):91-104. Epub 2013/03/07.eng.
63. Schlimp CJ, Ponschab M, Voelckel W, Treichl B, Maegele M, Schochl H. Fibrinogen levels in trauma patients during the first seven days after fibrinogen concentrate therapy: a retrospective study. Scand J Trauma Resusc Emerg Med. 2016;24(1):29. PubMed Central PMCID: PMC4788877, Epub 2016/03/13.eng.
64. Wikkelso AJ, Edwards HM, Afshari A, Stensballe J, Langhoff-Roos J, Albrechtsen C, et al. Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial. Br J Anaesth. 2015; 114(4):623-33. Epub 2015/01/15.eng.
65. Rahe-Meyer N, Levy JH, Mazer CD, Schramko A, Klein AA, Brat R, et al. Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy. Br J Anaesth. 2016;117(1):41-51. PubMed Central PMCID: PMC4913420, Epub 2016/06/19.eng.
66. Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A. Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. Journal of the American Heart Association. 2015;4(6). Epub 2015/06/04.eng.
67. Ranucci M, Baryshnikova E. Fibrinogen supplementation after cardiac surgery: insights from the Zero-Plasma trial (ZEPLAST). Br J Anaesth. 2016 Feb 17. Epub 2016/02/20. Eng.
68. Schochl H, Nienaber U, Maegele M, Hochleitner G, Primavesi F, Steitz B, et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentratebased therapy versus standard fresh frozen plasma-based therapy. Crit Care. 2011; 15(2):R83. PubMed Central PMCID: PMC3219338, Epub 2011/03/08.eng.
69. Jensen NH, Stensballe J, Afshari A. Comparing efficacy and safety of fibrinogen concentrate to cryoprecipitate in bleeding patients: a systematic review. Acta Anaesthesiol Scand. 2016 Apr 24. Epub 2016/04/26. Eng.
70. Curry N, Hopewell S, Doree C, Hyde C, Brohi K, Stanworth S. The acute management of trauma hemorrhage: a systematic review of randomized controlled trials. Crit Care. 2011;15(2):R92. PubMed Central PMCID: PMC3219356, Epub 2011/03/12.eng.
71. Stanworth SJ, Hunt BJ. The desperate need for good-quality clinical trials to evaluate the optimal source and dose of fibrinogen in managing bleeding. Crit Care. 2011;15(6):1006. PubMed Central PMCID: PMC3388654, Epub 2011/11/16.eng.
72. Winearls J, Reade M, Miles H, Bulmer A, Campbell D, Gorlinger K, et al. Targeted coagulation management in severe trauma: the controversies and the evidence. Anesth Analg. 2016;123(4):910-24. Epub 2016/09/17.eng.